Emergent BioSolutions (EBS) Capital Expenditures (2010 - 2026)
Emergent BioSolutions (EBS) posted Capital Expenditures of $2.1 million for Q2 2026, down 27.6% from $2.9 million a year earlier and down 12.5% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Capital Expenditures (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Emergent BioSolutions was $11.8 million, down 15.7% year-over-year; for FY2025, it came in at $13.8 million, down 39.7% from FY2024.
- Annual Capital Expenditures has declined for three consecutive years, with a five-year compound annual growth rate of -37.3% (FY2020 to FY2025).
- In prior years, Emergent BioSolutions' Capital Expenditures was $22.9 million in FY2024 (-55.6%), $51.6 million in FY2023 (-78.8%), $243.7 million in FY2022 (+8.7%) and $224.1 million in FY2021 (+57.9%).
- The Q2 2026 figure stands as the lowest quarterly Capital Expenditures since Q4 2024.
- On a year-over-year basis, Capital Expenditures increased in 1 of the last eight quarters, with an average decline of 26.9%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q3 2022, with growth of 225.0%; the weakest was Q3 2023, with a decline of 93.0%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $2.4 million (Q1 2026), $3.9 million (Q4 2025) and $3.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,147.40 Bn | 1,115.99 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 623.11 Bn | 541.63 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 509.31 Bn | 482.42 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 365.84 Bn | 320.22 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 297.69 Bn | 261.68 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.62 Bn | 235.30 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 235.65 Bn | 191.05 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.07 Bn | 168.27 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 171.97 Bn | 118.61 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Emergent BioSolutions | 325.08 Mn | -425.82 Mn | 137.20 Mn | 2.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.10 Mn |
| Mar 31, 2026 | 2.40 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Sep 30, 2025 | 3.40 Mn |
| Jun 30, 2025 | 2.90 Mn |
| Mar 31, 2025 | 3.60 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 5.80 Mn |
| Jun 30, 2024 | 4.60 Mn |
| Mar 31, 2024 | 10.80 Mn |
| Dec 31, 2023 | 11.40 Mn |
| Sep 30, 2023 | 12.60 Mn |
| Jun 30, 2023 | 12.50 Mn |
| Mar 31, 2023 | 15.10 Mn |
| Dec 31, 2022 | 23.60 Mn |
| Sep 30, 2022 | 271.60 Mn |
| Jun 30, 2022 | 32.10 Mn |
| Mar 31, 2022 | 32.20 Mn |
| Dec 31, 2021 | 45.80 Mn |
| Sep 30, 2021 | 55.20 Mn |
API Access
Emergent BioSolutions Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();